Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Gabbay

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Preventive Cardiology|April 17, 2012
A comparison of the acute haemodynamic response to aerobic and resistance exercise in subjects with exercise-induced pulmonary arterial hypertensionRobin M Fowler, Andrew J Maiorana, Sue C Jenkins, et al.
BMC Pulmonary Medicine|July 13, 2013
Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertensionJames Twiss, Stephen McKenna, Louise Ganderton, et al.
ERJ Open Research|May 21, 2024
Home spirometry appears accurate and feasible for monitoring chronic respiratory diseaseCaitlin L Wilson, Claire McLaughlin, Alvenia Cairncross, et al.
Internal Medicine Journal|December 11, 2021
The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causalityRosemary Smith, Megan Harrison, Kay-Vin Lam, et al.
American Heart Journal|August 13, 2018
The National Echocardiography Database Australia (NEDA): Rationale and methodologyGeoff Strange, David S Celermajer, Tom Marwick, et al.
Journal of the American College of Cardiology|June 1, 2019
Threshold of Pulmonary Hypertension Associated With Increased MortalityGeoff Strange, Simon Stewart, David S Celermajer, et al.
Arthritis Research & Therapy|October 9, 2012
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort studyGene-Siew Ngian, Wendy Stevens, David Prior, et al.
Immunotherapy|February 25, 2025
Immunotherapy rechallenge after significant toxicity - can it be done successfully?Ashley Tan, Tara McSweeney, Nisha Sikotra, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Preventive Cardiology|April 17, 2012
A comparison of the acute haemodynamic response to aerobic and resistance exercise in subjects with exercise-induced pulmonary arterial hypertensionRobin M Fowler, Andrew J Maiorana, Sue C Jenkins, et al.
BMC Pulmonary Medicine|July 13, 2013
Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertensionJames Twiss, Stephen McKenna, Louise Ganderton, et al.
ERJ Open Research|May 21, 2024
Home spirometry appears accurate and feasible for monitoring chronic respiratory diseaseCaitlin L Wilson, Claire McLaughlin, Alvenia Cairncross, et al.
Internal Medicine Journal|December 11, 2021
The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causalityRosemary Smith, Megan Harrison, Kay-Vin Lam, et al.
American Heart Journal|August 13, 2018
The National Echocardiography Database Australia (NEDA): Rationale and methodologyGeoff Strange, David S Celermajer, Tom Marwick, et al.
Journal of the American College of Cardiology|June 1, 2019
Threshold of Pulmonary Hypertension Associated With Increased MortalityGeoff Strange, Simon Stewart, David S Celermajer, et al.
Arthritis Research & Therapy|October 9, 2012
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort studyGene-Siew Ngian, Wendy Stevens, David Prior, et al.
Immunotherapy|February 25, 2025
Immunotherapy rechallenge after significant toxicity - can it be done successfully?Ashley Tan, Tara McSweeney, Nisha Sikotra, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Pageof 5